CANADA LIFE ASSURANCE Co reduced its stake in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 14.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 28,485 shares of the company's stock after selling 5,005 shares during the quarter. CANADA LIFE ASSURANCE Co's holdings in Molina Healthcare were worth $8,291,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Wellington Management Group LLP grew its holdings in shares of Molina Healthcare by 7.4% in the fourth quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock valued at $766,111,000 after purchasing an additional 181,073 shares during the period. FMR LLC grew its holdings in shares of Molina Healthcare by 31.1% in the fourth quarter. FMR LLC now owns 1,801,113 shares of the company's stock valued at $524,214,000 after purchasing an additional 427,276 shares during the period. Geode Capital Management LLC grew its holdings in shares of Molina Healthcare by 2.5% in the fourth quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company's stock valued at $417,144,000 after purchasing an additional 34,992 shares during the period. Invesco Ltd. grew its holdings in shares of Molina Healthcare by 28.5% in the fourth quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock valued at $386,229,000 after purchasing an additional 294,180 shares during the period. Finally, Norges Bank purchased a new stake in shares of Molina Healthcare in the fourth quarter valued at about $134,675,000. 98.50% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities research analysts recently issued reports on the stock. Guggenheim assumed coverage on shares of Molina Healthcare in a report on Wednesday, April 9th. They issued a "neutral" rating for the company. Sanford C. Bernstein assumed coverage on shares of Molina Healthcare in a report on Tuesday, April 22nd. They issued an "outperform" rating and a $414.00 price objective for the company. Robert W. Baird reissued a "neutral" rating and issued a $375.00 price objective (up previously from $331.00) on shares of Molina Healthcare in a report on Tuesday, April 15th. Mizuho increased their target price on shares of Molina Healthcare from $376.00 to $400.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 9th. Finally, Barclays increased their target price on shares of Molina Healthcare from $339.00 to $362.00 and gave the stock an "equal weight" rating in a research note on Friday. Nine equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, Molina Healthcare presently has a consensus rating of "Hold" and an average price target of $365.38.
Get Our Latest Research Report on MOH
Insider Activity at Molina Healthcare
In related news, Director Steven J. Orlando sold 1,000 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the sale, the director now owns 17,375 shares of the company's stock, valued at $5,235,608.75. This trade represents a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.10% of the stock is owned by corporate insiders.
Molina Healthcare Stock Up 1.9 %
Shares of NYSE MOH traded up $6.00 during midday trading on Monday, hitting $320.51. The company's stock had a trading volume of 624,444 shares, compared to its average volume of 672,357. The business's fifty day simple moving average is $320.07 and its two-hundred day simple moving average is $307.33. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62. Molina Healthcare, Inc. has a 1 year low of $262.32 and a 1 year high of $365.23. The firm has a market capitalization of $17.53 billion, a price-to-earnings ratio of 15.69, a price-to-earnings-growth ratio of 1.06 and a beta of 0.70.
Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, beating the consensus estimate of $5.96 by $0.12. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The business had revenue of $11.15 billion during the quarter, compared to analyst estimates of $10.86 billion. During the same quarter last year, the firm posted $5.73 earnings per share. The business's revenue for the quarter was up 12.2% compared to the same quarter last year. On average, equities analysts predict that Molina Healthcare, Inc. will post 24.4 EPS for the current year.
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Further Reading

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.